Dr. Vishal Dahya, MD

Dr. Dahya practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Dahya's NPI, 1538571195, was assigned on May 29, 2014. Dr. Dahya graduated from Florida State University College Of Medicine in 2014. Dr. Dahya's Alabama license number on file is 42967.

Dr. Dahya's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Dr. Dahya's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Dahya to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dahya practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Dahya's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Dahya is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Dahya's licenses on file in 4 states: Alabama, Florida, Pennsylvania and Ohio.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, chronic hypertension, chronic skin ulcer and coronary artery disease among the conditions Dr. Dahya treats.

CMS data shows 2,769 Medicare services from Dr. Dahya across 32 procedure codes in 2024, for 828 Medicare patients. Medicare paid $184,199 for them.

CMS counts 828 Medicare patients who saw Dr. Dahya in 2024. The largest group is 65 to 74, with 351 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dahya's median patient age at 70, with 54% women.

In 2024, Dr. Dahya wrote 3,595 Medicare Part D claims for 722 patients. 80% of them were for generic drugs. CMS names the drug for 3,379 of them, across 45 drugs with 11 or more claims each, at $591,210 in total drug cost. In 2023, CMS named 2,831 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Dahya for performance year 2024, reported as part of a group. Dr. Dahya accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Dahya, published from 2013 to 2020. 2019 was the busiest year, with 4. The most frequent topics are Endocarditis, Bacterial, Tomography, X-Ray Computed and Coronary Angiography. Dr. Dahya has published most often in Am J Med Sci. Dr. Dahya's most frequent co-authors are Wayne B. Batchelor, MD, Prasad Vrk Chalasani, MD and Thomas Everett Noel, MD.

CMS Open Payments shows 173 general payments to Dr. Dahya from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Abbott Laboratories paid the most, $594.

Dr. Dahya graduated from Florida State University College Of Medicine in 2014.

Dr. Dahya is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.